Sunell Receives FDA Warning Letter

By Isabella Cheng, Published Mar 16, 2021, 11:06am EDT (Info+)

The US FDA has sent a warning letter to Sunell due to its sales of "adulterated and misbranded products", i.e. its widely relabelled Panda Cams.

In response, Sunell has taken down the problematic marketing and told IPVM "no more marketing multi-people scanning for fever cameras."

IPVM Image

** **** ******, **** ********:

  • *** *** ******* ******
  • ***** *** *** ***** ****** ********
  • ********* "** ** ** ******" ************ scanning ******
  • ****** *********** ******* ******** ****** ********
  • *** ****** ******* ***********
  • ****** ********

FDA ****** ******* ****** ** ****** *** "*********** *** ********** ********"

*** *** *** ****** ******** ******** ****** *** ******* ******* ******* marketing *** ******* ** **** ******** people **************.

IPVM Image

**** ******* ***** *** *** ****** similar ******* **** ***** ******* ******* ****** *********, ** **** ******** ******* **** month.

"Panda ***" ****** *****

******'* "***** ***" *** ****** **** OEMed ********** *** ******** *** *** easily ** ******** ********** *** ** its ****** ****** (*.*. ***** **** and ****).** ***** ** ************ *********** ** ** **** ***** relabeled *** ***** ***, *** **** widely ******** ** ***** ** **** security ****** ******** *****.

IPVM Image

2 ***** ****** ******* ****** ****** ********

******** ******'* ***** *** ** *** product **** ** **** ****** ***** and ************, *** ***'* ******* ****** also ******* ** ******'* "*********** ********* Thermographic ******* ****** ******" (**-***-*) *** "** ***** ********* ******* Camera **** ********** *********" (**-***-*-*). **** ** ***** ******* **** advertised ******** *********, ** ** ** targets *** *** ****** *** ** targets *** *** ******.

IPVM Image

***** *** ****** **** ******** ****** after *** ***** *** (** **** 2020 *** ***** ****), ***** ** likely *** **** **** *** **** as ************* **********.

Sunell ********* "******** *********" (** ** ** ******) ********* ******

** *** ****, ************* ***** *** *** ******* *** that ******'* ********* ** ******** ******** people (** **** ***** ** ** 45 ******) **** ************* ************** ******** ** ***** ******* *** conflicted **** *** *** *********** ***************.

****** *** ********** **** ********* ****** showing *** ****** ******** ** ** 45 ****** ** * ****.

IPVM Image

*** ***** ***'* ******* (************) *********** ****** ******** "** ** 45 *******."

IPVM Image

** *** **** *******, ****** ****** an ***** ** ****** ** ****** being ************** *******.

IPVM Image

********, ******'* ********* ********* ******** **** its *** *********** **********, ***** *** subjects ** ******** *** ****** ** a ****** **** ****, ******* ** walk **** *** *********, *** ****** straight ****** *** ******.

IPVM Image

*** *** *** *** ******** ******'* aggressive ********* ****** *** **** *** company * ******* ****** ***** ***** claims.

Not *** *** ********

*** ***, ***** *** ****, *** repeatedly *** ********** ****** ******* ******* systems ********** ******* *** ******** * ****. **** ** *** new ******** *** ****** *** **** thermal ******* ****** ********* ** ********.

Relabellers ********* ***** "********" *********

**** ********* ********* ******* "********" ****** screening ******* ** ******'* *********'* ********* materials. * *** ******** ** ********* faked ***/** ******* ********* ********* *** examined *****.

*****

***** *** **** ***** ********* ******** people ******** *** ****** ******** ******** screening *********** *** *******, **** ** **** ******* ***** (captured *****), **** **** ***** ** a ***** ** ***** ******** ****** are ******* ** ****:

IPVM Image

***** ******** * ***** ***** ******* * ********* ***** **** ****** 2020:

IPVM Image

******

******'********** ***************** ***** ** ********* ******** ***** of ******** ****** ***** *******. ******** people ** **** ***** **** **** on ** *****, ***** ***** ******** an ******** ****, ********** ***** *** Panda *** **** *** ******* ***** canthus ******** *** **** ******** ********. Further, *** ***** ***** ***** ** people **** ***** ***** ******* ****/****** away **** *** ******.

IPVM Image

*****, ****** ***** **** *** ****** can ****** ** ** ** *******.

IPVM Image

***********

************** **** ***** ******** ********* ** up ** ** ******, *** **** that **** *** ** ******. ***** on ****'* **** ***** ** ********* thermal ******** *******, ***** *** *********** challenges *** ********** ********* *** *********** of ****** ********, **** **** ** people *** ******.

IPVM Image

********

************ ****** ******** ****** ********* (**-** people ** ****). ** ****** *** Panda *** ** * "****** ******" ***** ****** *** ****** ** top ** * ******* ****. ***** DuThermX's ********* **** *** ****** ** "capable ** ******** **-** ******* **************," its ****** ****** ******* ***** **** people ****** ***** *** ******** **** either ** * ****** ** ****** lane *************. *****, **** "******** ****** detection" ***** ******* **** *********** **********.

IPVM ImageIPVM Image

FDA ********** ***** ***********, *** ****** ****** *****

*** *** *** ***** ******* ******* to *** **********, *** **** ** only ***** ** * ****** ********** that ***, ** ***, ******** * similar ******. ********, ***** **** ******** under ***** ********** *****, *** ********* ******* ********** *** *** *** *** **** reasons ****** ** ******. *****, ********'************* *********** ***** "******** ****** *********." Other ********* **** *** **** ***** blatantly ***** *********** (**** ** ***** specified ** **** ******) **** *** received ******* ********* ***** ***'* ******* ****** ********.

*** **** ** ******* ******* ****** to *********** ** * ***** ***** because *********** *** *********** *** **** of *** ****** ***** ** ***** cameras ** ***-*****. ** ******** ****** risk, *** *** **** *************** ****** the ********* ********* ** *** ****** relabellers *** *** ***********.

Sunell ********

**** ********* ***** *** *** ******* letter, ****** **** ****:

****** *** ********* ******** *** ******* letter *** **** **** ** ******** respond ** **** ** ********. ** the **** ****, *** **** *** already **** ********** ** ******* *** issues *** *** ******** ** **. We've ******* *** ************ ** *** FDA ******* *** ******* *** ******** descriptions *******. ***** **** ** ** more ********* *****-****** ******** *** ***** cameras.

******, ** ** ***** **, ****, the * ******** ****** ******' ****** webpages ** ****** ***** *****-****** *********.

** ***** **, ****** ****** **** IPVM *** ************* ******** *** ***, ********* ****** *** "removed *** ******* *** *********** ********* and ******* ***********" ****** * ***** of ********* *** ******* ******, ********* screenshots ** ******'* ******* ******* ***** the *******.

Comments (7)

**** ****** ****** ***** ****. ** pun ******** 🤣😂

Agree
Disagree
Informative
Unhelpful
Funny

**** *********. *************, *****'* *** ****** of **. ********* *********** ******** ** ad-dependent ** ****** *****-**** ** ******** makers *** *******. ** **** ******** it's ******** ***** *** *** ******, too- ****** *** ** ***** ****** it **** ******** ** ********.

Agree: 1
Disagree
Informative
Unhelpful
Funny

*** *** ***** ****** ***** ****** this *****?

Agree
Disagree
Informative
Unhelpful
Funny

** *** **** ** *** ****, not **** ***** **** *** ********* greatly ******* ***** *** *****.

* ** ***** *** *********** ******* is ** *** ****** ***** ******* last **** ******** ** *****-****** ******** (which ** **** ***** *** ******* Sunell *********** **** ****), **** *** should **? *** *** ******** ** sue *** * ****** ** *** damages **** ***** * ******* **** violates *** ***********?

Agree
Disagree
Informative: 2
Unhelpful
Funny

*** *** ******** ** *** *** a ****** ** *** ******* **** using * ******* **** ******** *** regulations?

*'* **** *****'* * **** **** for ***** ** *** ****** ** go ******* *** ****, ******* *** expense ** ***** **. *** **'* dependent ** *** ****** ***** **** to ***** ********** ***** *** ********* they **** ***** *** ***** ** by *** ***** *****. **** ** facility ******** *** ****** ***** ******* might ** **** ******** ** ** that, ************ **** *** ******** ***** down *** *** **** *** **** solutions **********.

*'* **** **** ******* ******** *** now **** **** **** **** *** issue ***** **** (***** ** *** same **** ******* ** ***** ****** black ***** ** ******* *** ***** the ***** ** ****** *** **** them ** *** ********).

Agree: 1
Disagree
Informative
Unhelpful
Funny

*** **'* ********* ** *** ****** going **** ** ***** ********** ***** and ********* **** **** ***** *** taken ** ** *** ***** *****. Lots ** ******** ******** *** ****** board ******* ***** ** **** ******** to ** ****

* ***** ***** ****, **** *.*.,*** ********** **** **** ****** $***,*** of ********* *** ***** *******, ****'* ** ******* **** ** being ***** (*** ********* *** **********) but **** ***** **** **, ****** than ***** ***** *******.

Agree
Disagree
Informative: 1
Unhelpful
Funny

******: ***** *** ******* *** *******, removing ***** ****** *** ****** *** video ******* **** *** *** ********** *** ******* ** ******* *** individual ** * ****:

IPVM Image

**** ** **********. ***** ***** * year ****** ****** ** *** ***** products ***** ** *** '*******' ** screen ****** ** ****** ** **** and *** **** **** **** ***** money, **** ** *** *** '***, actually ** **** ********* ********* *** individual ** * ****.'

Agree: 1
Disagree
Informative
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports